ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• 4 Ways Home Visits Support Successful Rare Disease Clinical Trials

  Researchers, patients, pharma, and regulators face several obstacles when designing and conducting rare disease trials. Here, we delve into the importance of home visits in rare disease clinical trials.

• Are You Aiming For The Bullseye Or Just The Target?

  Learn what this author has to say about focusing on a clinical trial's outcome when developing Risk-Based Quality Management strategies.

• Effective Use Of IRT In Decentralized And Hybrid Clinical Trials

  Uncover the ways interactive response technologies are helping trial sponsors manage the distribution of medications, forecast trial supply, and integrate workflows with other technology platforms.

• Navigating The Complexities Of Publication Planning

  In the dynamic landscape of the life sciences industry, Medical Affairs (MA) teams and accessible digital platforms are pivotal in navigating the complexities of medical publication planning.

• 5 Ways To Get Ready For IRT Regulatory Inspections

  Preparing for a regulatory inspection during a clinical trial can be daunting. Learn about the importance of clear roles, audit trails, data integrity, and training, and get recommendations to help.

• Overcoming Real-World Data Capture Challenges In Phase 4 Trials

  As the demand for real-world insights continues to grow, learn why navigating challenges and leveraging emerging opportunities becomes crucial for advancing clinical research in the real-world setting.

• Clinical Data Needs Smart Automation Now for a Better AI Future

  AI holds the potential to enhance clinical trial efficiency, but it relies on a foundation of clean data and intelligent automation to be effective.

• Everest Group Life Sciences EDC Products PEAK Matrix^® Assessment 2024

  This Everest Group report examines Medidata’s Rave EDC and its impact on the clinical development value chain of life sciences.

• Can Your Clinical Trial Design Handle Mid-Study Changes?

  Mid-study changes are frequently inevitable, but it’s possible to reduce the downtime they create with strategic planning and technology. See how to plan for mid-study changes that mitigate downtime.

• The Benefits Of Mobile EDC Access

  As clinical studies become increasingly decentralized, learn why study teams need to be able to monitor the influx of data in real time to ensure the integrity and success of modern trials.